Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Striatonigral Atrophy

3,4-dihydroxyphenylacetic acid has been researched along with Striatonigral Atrophy in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research Excerpts

ExcerptRelevanceReference
"Melatonin has ubiquitous actions, both as a direct free-radical scavenger and as an indirect anti-oxidant."1.38Neuroprotective effects of melatonin on the nigrostriatal dopamine system in the zitter rat. ( Ehara, A; Hashimoto, K; Hirata, K; Sakakibara, S; Ueda, S; Yoshimoto, K, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, K1
Ueda, S1
Ehara, A1
Sakakibara, S1
Yoshimoto, K1
Hirata, K1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Striatonigral Atrophy

ArticleYear
Neuroprotective effects of melatonin on the nigrostriatal dopamine system in the zitter rat.
    Neuroscience letters, 2012, Jan-06, Volume: 506, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Cytokines; Disease Models, Animal; Dopamin

2012